Evaluation and solubility improvement of Carvedilol: PSC[n]arene inclusion complexes with acute oral toxicity studies

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 73, Issue 1-4, 2012, Pages 295-303

  Menon, Shobhana K ^a   Mistry, Bhoomika R ^a   Joshi, Kuldeep V ^a   Modi, Nishith R ^a   Shashtri, Divyesh ^a  

^a GUJARAT UNIVERSITY   (India)

Author keywords

Acute oral toxicity; Carvedilol; Dissolution study; Inclusion complex; Phase solubility study; PSC n arene

Indexed keywords

EID: 84862635256     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-011-0056-x     Document Type: Article

References (37)

1. T Loftsson P Jarho M Masoon T Jarvinen 2005 Cyclodextrins in drug delivery Expert Opin. Drug Deliv. 2 335 351 10.1517/17425247.2.1.335 1:CAS:528:DC%2BD2MXjsFantrY%3D
2. J Xian J Loh 2008 Cyclodextrin-based supramolecular architectures: syntheses, structures, and applications for drug and gene delivery Adv. Drug Deliv. Rev. 60 1000 1017 10.1016/j.addr.2008.02.011
3. C Gutsche B Dhawan H Kwang R Muthukrishnan 1981 Calixarenes. 4: the synthesis, characterisation and properties of the calixarenes from p-tert butylphenol J. Am. Chem. Soc. 103 13 3782 3792 10.1021/ja00403a028 1:CAS:528:DyaL3MXksVamtr0%3D
4. Gutsche, C., Stoddart, C.: Calixarenes Revisited Monographs in Supramolecular Chemistry. The Royal Society of Chemistry, Cambridge (1998)
5. Vicens, J., Bohmer, V.: Calixarenes: A Versatile Class of Macrocyclic Compounds. Kluwer, Dordrecht (1991)
6. Perret, F., Lazar, A., Coleman, A.: Biochemistry of the para-sulfonato-calix[n]arenes. Chem. Commun. 2425-2438 (2006)
7. Antman, E.: Cardiovascular therapeutics: a companion to Braunwald's heart disease, pp. 99, 100 (2009)
8. M Zhao H Wang B Yang H Tao 2010 Identification of cyclodextrin inclusion complex of chlorogenic acid and its antimicrobial activity Food Chem. 120 1138 1142 10.1016/j.foodchem.2009.11.044 1:CAS:528:DC%2BC3cXht1Krur0%3D
9. R Ficarra P Ficarra M Di Bella D Raneri S Tommasini M Calabro M Gamberini 2000 Study of b-blockers: b-cyclodextrins inclusion complex by NMR, DSC, X-ray and SEM investigation J. Pharm. Biomed. Anal. 23 33 40 10.1016/S0731-7085(00) 00261-2 1:CAS:528:DC%2BD3cXktlCrtr8%3D
10. S Jun M Kim J Kim H Park S Lee J Woo S Hwang 2007 Preparation and characterization of simvastatin/hydroxypropyl-b-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process Eur. J. Pharm. Biopharm. 66 413 421 10.1016/j.ejpb.2006.11.013 1:CAS:528:DC%2BD2sXlsFKmtbs%3D
11. N Sapkal V Kilor K Bhusari A Daud 2007 Evaluation of some methods for preparing gliclazide-β-cyclodextrin inclusion complexes Trop. J. Pharm. Res. 6 4 833 840 10.4314/tjpr.v6i4.14667
12. H Ganapathy M Lee C Park K Lim 2008 Sustained release applications of a fluoroalkyl ester-functionalized amphiphilic cyclodextrin by inclusion complex formation with water-soluble drugs in supercritical carbon dioxide J. Fluor. Chem. 129 1162 1166 10.1016/j.jfluchem.2008.09.005 1:CAS:528:DC%2BD1cXhsVSqurfM
13. Y Lu X Zhang J Lai Z Yin W Wua 2009 Physical characterization of meloxicam-cyclodextrin inclusion complex pellets prepared by a fluid-bed coating method Particuology 7 1 8 10.1016/j.partic.2008.11.004
14. C Leea S Kima Y Youna E Widjojokusumoa E Leea J Kimb Y Leea R Tjandrawinatac 2010 Preparation of bitter taste masked cetirizine dihydrochloride/cyclodextrin inclusion complex by supercritical antisolvent (SAS) process J. Supercrit. Fluids 55 348 357 10.1016/j.supflu.2010.05.028
15. A Dóris de Castroa N Silva Jr B Curya R Evangelistaa L Freitas M Gremiãoa 2010 A new approach to the granulation of cyclodextrin inclusion complexes Chem. Eng. J. 164 316 321 10.1016/j.cej.2010.05.031
16. X Wen F Tan Z Jing Z Liu 2004 Preparation and study the 1:2 inclusion complex of CDL with cyclodextrin J. Pharm. Biomed. Anal. 34 517 523 10.1016/S0731-7085(03)00576-4 1:CAS:528:DC%2BD2cXptFehuw%3D%3D
17. G Chaulmaot C Yao V Pino J Anderson 2009 Determining the stoichiometry and binding constants of inclusion complexes formed between aromatic compounds and β-cyclodextrin by solid-phase microextraction couple to high-performance liquid chromatography J. Chromatogr. A 1216 5242 5248 10.1016/j.chroma.2009.05.017
18. B Shewale N Sapkal N Raut N Gaikwad R Fursule 2008 Effect of hydroxypropyl-β-cyclodextrin on solubility of carvedilol Indian J. Pharm. Sci. 70 2 255 257 10.4103/0250-474X.41470 1:STN:280:DC%2BC3c%2FgtlGltw%3D%3D
19. Y Liu B Han Y Chen 2000 Inclusion complexation of acridine red dye by calixarenesulphonates and cyclodextrins: opposite fluorescent behaviour J.Org. Chem. 65 6227 6230 10.1021/jo991654x 1:CAS:528:DC%2BD3cXmsl2mt7s%3D
20. T Arimura T Nagasaki S Shinkai T Matsuda 1989 Thermodynamic study of p-sulfonated calixarene complexes in aqueous solution J. Org. Chem. 54 3766 3768 10.1021/jo00277a003 1:CAS:528:DyaL1MXltlemur8%3D
21. J Panchal R Patel S Menon 2010 Preparation and physicochemical characterization of carbamazepine (CBMZ): para-sulfonated calix[n]arene inclusion complexes J. Incl. Phenom. Macrocycl. Chem. 67 8 201 208 10.1007/s10847-009-9698-3 1:CAS:528:DC%2BC3cXlsFOhtL4%3D
22. Menon, S., Modi, N., Mistry, B., Joshi, K.: Improvement of some pharmaceutical properties of mycophenolate mofetil (MMF) by para sulphonatocalix[4]resorcinarene inclusion complex. J. Incl. Phenom. Macrocycl. Chem. 70, 121-128 (2011)
23. S Shinkai S Mori H Koreishi T Tsubaki O Manabe 1986 Hexasulfonated calix[6]arene derivatives: a new class of catalysts, surfactants, and host molecules J. Am. Chem. Soc. 108 9 2409 2416 10.1021/ja00269a045 1:CAS:528:DyaL28XhvVGksrY%3D
24. T Higuchi K Connors 1965 Phase-solubility techniques Adv. Anal. Chem. Instrum. 4 117 212 1:CAS:528:DyaF2MXktlGitrg%3D
25. P Swamy H Shilpa S Shirsand S Gada M Kinagi 2010 Role of cogrinding in enhancing the in vitro dissolution characteristics of carvedilol Int. J. Pharma Sci. Res. 1 5 232 237 1:CAS:528:DC%2BC3cXhtlKqtL7I
26. S Bhutani S Hiremath P Swamy S Raju 2007 Preparation and evaluation of inclusion complexes of carvedilol J. Sci. Ind. Res. 66 830 834 1:CAS:528:DC%2BD2sXht1KhtbnI
27. Eugene, F.F., Timothy, A.H.: In: Lachmann, L., Liberman, H.A., Kanig, J.L. (eds.) The Theory and Practice of Industrial Pharmacy, 3rd edn, p. 171. Varghese Publishing House, Mumbai (1987)
28. I García-Sosa F María Ramírez 2010 Synthesis, solid and solution studies of paraquat dichloride calixarene complexes. molecular modelling J. Mex. Chem. Soc. 54 3 143 152
29. Vogel, H., Vogel, W.: Drug discovery and evaluation: pharmacological analysis. Springer, Berlin (1997)
30. A Mohamed A Hussein S Bhathena Y Hafez 2002 The effect of dietary menhaden olive and coconut oil fed with three levels of vitamin E on plasma and liver lipids and plasma fatty acid composition in rats J. Nutr. Biochem. 13 435 441 10.1016/S0955-2863(02)00196-1 1:CAS:528:DC%2BD38Xlt12lu7c%3D
31. Chadha, R., Saini, A., Gupta, S., Arora, P., Thakur, D., Jain, D.: Encapsulation of rifampicin by natural and modified b-cyclodextrins: characterization and thermodynamic parameters., J. Incl. Phenom. Macrocycl. Chem. 67:1-2, 109-116. doi: 10.1007/s10847-009-9682-y
32. D Araujo S Tsuneda M Cereda F Gel G Carvaiho P Prete S Fernandes F Yokaichiya M Franco I Mazzaro L Fraceto A De F Braga E Paula 2008 Development and pharmacological evaluation of ropivacaine-2-hydroxypropyl-beta-cyclodextrin inclusion complex Eur. J. Pharm. Sci. 33 60 71 10.1016/j.ejps.2007.09.010
33. 1H NMR and ROSEY experiments Eur. J. Pharm. Sci. 18 285 296 10.1016/S0928-0987(03)00025-3
34. P Nalawade B Aware N Dand V Kadam R Hirlekar 2009 Solid state characterization of the inclusion complex of valsartan with methyl b-cyclodextrin J. Incl. Phenom. Macrocycl. Chem. 65 377 383 10.1007/s10847-009- 9595-9
35. V Kadam S Gattani 2009 Dissolution enhancement of carvedilol by using surfactant as a coating material Asian J. Pharm. Clin. Res. 2 3
36. Murthy, T., Sowjanya, G.: Development of discriminatory method for dissolution of carvedilol marketed formulations. Int. J. ChemTech Res. 2, 1047-1050 (2010)
37. http://www.accessdata.fda.gov/drugsatfda-docs/label/2005/020297s013lbl. pdf. NDA 20-297/S-013 (2005)